589 related articles for article (PubMed ID: 27795350)
1. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.
Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M
J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350
[TBL] [Abstract][Full Text] [Related]
2. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
3. Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins.
Groen J; van den Hoogen BG; Burghoorn-Maas CP; Fooks AR; Burton J; Clegg CJ; Zeller H; Osterhaus AD
Microbes Infect; 2003 Apr; 5(5):379-85. PubMed ID: 12737993
[TBL] [Abstract][Full Text] [Related]
4. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.
Bramble MS; Hoff N; Gilchuk P; Mukadi P; Lu K; Doshi RH; Steffen I; Nicholson BP; Lipson A; Vashist N; Sinai C; Spencer D; Olinger G; Wemakoy EO; Illunga BK; Pettitt J; Logue J; Marchand J; Varughese J; Bennett RS; Jahrling P; Cavet G; Serafini T; Ollmann Saphire E; Vilain E; Muyembe-Tamfum JJ; Hensely LE; Simmons G; Crowe JE; Rimoin AW
J Infect Dis; 2018 Nov; 218(12):1929-1936. PubMed ID: 30107445
[TBL] [Abstract][Full Text] [Related]
5. Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea.
Fischer K; Camara A; Troupin C; Fehling SK; Strecker T; Groschup MH; Tordo N; Diederich S
Transbound Emerg Dis; 2020 Mar; 67(2):724-732. PubMed ID: 31627257
[TBL] [Abstract][Full Text] [Related]
6. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
[TBL] [Abstract][Full Text] [Related]
7. Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study.
Diallo MSK; Ayouba A; Keita AK; Thaurignac G; Sow MS; Kpamou C; Barry TA; Msellati P; Etard JF; Peeters M; Ecochard R; Delaporte E; Toure A;
Lancet Microbe; 2021 Dec; 2(12):e676-e684. PubMed ID: 35544108
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
9. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.
Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R
Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425
[TBL] [Abstract][Full Text] [Related]
10. Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses.
Natesan M; Jensen SM; Keasey SL; Kamata T; Kuehne AI; Stonier SW; Lutwama JJ; Lobel L; Dye JM; Ulrich RG
Clin Vaccine Immunol; 2016 Aug; 23(8):717-24. PubMed ID: 27335383
[TBL] [Abstract][Full Text] [Related]
11. Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies.
Ravichandran S; Khurana S
EBioMedicine; 2022 Aug; 82():104186. PubMed ID: 35901660
[TBL] [Abstract][Full Text] [Related]
12. Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants.
Shu Q; Kenny T; Fan J; Lyon CJ; Cazares LH; Hu TY
PLoS Pathog; 2021 Nov; 17(11):e1010039. PubMed ID: 34748613
[TBL] [Abstract][Full Text] [Related]
13. Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection.
Rimoin AW; Lu K; Bramble MS; Steffen I; Doshi RH; Hoff NA; Mukadi P; Nicholson BP; Alfonso VH; Olinger G; Sinai C; Yamamoto LK; Ramirez CM; Okitolonda Wemakoy E; Kebela Illunga B; Pettitt J; Logue J; Bennett RS; Jahrling P; Heymann DL; Piot P; Muyembe-Tamfum JJ; Hensley LE; Simmons G
J Infect Dis; 2018 Jan; 217(2):223-231. PubMed ID: 29253164
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Diagnostic Performance of Three Indirect Enzyme-Linked Immunosorbent Assays for the Detection of IgG Antibodies to Ebola Virus in Human Sera.
Paweska JT; Moolla N; Storm N; Msimang V; Conteh O; Weyer J; Vuren PJV
Viruses; 2019 Jul; 11(8):. PubMed ID: 31344850
[TBL] [Abstract][Full Text] [Related]
15. Analysis of CD8
Sakabe S; Sullivan BM; Hartnett JN; Robles-Sikisaka R; Gangavarapu K; Cubitt B; Ware BC; Kotliar D; Branco LM; Goba A; Momoh M; Sandi JD; Kanneh L; Grant DS; Garry RF; Andersen KG; de la Torre JC; Sabeti PC; Schieffelin JS; Oldstone MBA
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7578-E7586. PubMed ID: 30038008
[TBL] [Abstract][Full Text] [Related]
16. Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.
Marzi A; Ebihara H; Callison J; Groseth A; Williams KJ; Geisbert TW; Feldmann H
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1066-74. PubMed ID: 21987743
[TBL] [Abstract][Full Text] [Related]
17. Development of Prototype Filovirus Recombinant Antigen Immunoassays.
Boisen ML; Oottamasathien D; Jones AB; Millett MM; Nelson DS; Bornholdt ZA; Fusco ML; Abelson DM; Oda S; Hartnett JN; Rowland MM; Heinrich ML; Akdag M; Goba A; Momoh M; Fullah M; Baimba F; Gbakie M; Safa S; Fonnie R; Kanneh L; Cross RW; Geisbert JB; Geisbert TW; Kulakosky PC; Grant DS; Shaffer JG; Schieffelin JS; Wilson RB; Saphire EO; Branco LM; Garry RF; Khan SH; Pitts KR;
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S359-67. PubMed ID: 26232440
[TBL] [Abstract][Full Text] [Related]
18. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein.
Changula K; Yoshida R; Noyori O; Marzi A; Miyamoto H; Ishijima M; Yokoyama A; Kajihara M; Feldmann H; Mweene AS; Takada A
Virus Res; 2013 Sep; 176(1-2):83-90. PubMed ID: 23702199
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
[TBL] [Abstract][Full Text] [Related]
20. Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.
Sobarzo A; Perelman E; Groseth A; Dolnik O; Becker S; Lutwama JJ; Dye JM; Yavelsky V; Lobel L; Marks RS
Clin Vaccine Immunol; 2012 Nov; 19(11):1844-52. PubMed ID: 22993411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
